Miltefosine for the treatment of cutaneous leishmaniasis—A pilot study from Ethiopia

BACKGROUND: Cutaneous leishmaniasis (CL) in Ethiopia, caused by Leishmania aethiopica, is often severe and hard to treat compared to CL caused by other species elsewhere. Miltefosine is the only oral anti-leishmanial drug, with a favorable side-effect profile compared to routinely available sodium s...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS Negl Trop Dis
Prif Awduron: van Henten, Saskia, Tesfaye, Annisa Befekadu, Abdela, Seid Getahun, Tilahun, Feleke, Fikre, Helina, Buyze, Jozefien, Kassa, Mekibib, Cnops, Lieselotte, Pareyn, Myrthe, Mohammed, Rezika, Vogt, Florian, Diro, Ermias, van Griensven, Johan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2021
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8191986/
https://ncbi.nlm.nih.gov/pubmed/34048461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0009460
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg